Dishman has been selected as the preferred contract manufacturer for Codexis. Dishman will use Codexis' biocatalysis technology to manufacture building blocks, intermediates and APIs for innovator pharmaceutical companies. Dishman will also offer the technology to its own customers. Codexis will also collaborate with Ampac Fine Chemicals to expand the application of its technology.
Codexis
Wednesday 17 February 2010
Codexis selects Dishman and Ampac Fine Chemicals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment